We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals

hedge funds and large institutions have $7.45M invested in Tonix Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $6.07M → $7.45M (+$1.38M)

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$2.21M
BRF
2
B. Riley Financial
California
$1.64M
OM
3
Opaleye Management
Massachusetts
$1.6M
Vanguard Group
4
Vanguard Group
Pennsylvania
$799K
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$388K
KCM
6
Kingdon Capital Management
New York
$279K
ARTA
7
A.R.T. Advisors
New York
$167K
BlackRock
8
BlackRock
New York
$97K
OC
9
Oppenheimer & Co
New York
$87K
Millennium Management
10
Millennium Management
New York
$80K
TSS
11
Two Sigma Securities
New York
$59K
Morgan Stanley
12
Morgan Stanley
New York
$22K
PCM
13
Prelude Capital Management
New York
$11K
Deutsche Bank
14
Deutsche Bank
Germany
$8K
UBS Group
15
UBS Group
Switzerland
$2K
Bank of America
16
Bank of America
North Carolina
$1K
Creative Planning
17
Creative Planning
Kansas
$1K
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$1K
Wells Fargo
19
Wells Fargo
California
$1K
Bank of Montreal
20
Bank of Montreal
Ontario, Canada
-$93K
Citadel Advisors
21
Citadel Advisors
Florida
-$119K
CG
22
Cutler Group
California
-$5K
DCM
23
DAFNA Capital Management
California
-$93K
FMA
24
FNY Managed Accounts
New York
-$88K
Geode Capital Management
25
Geode Capital Management
Massachusetts
-$47K